speb/financial-data huggingface dataset:
Financial ratios for BTCT — annual report dated 2024-12-31
Total revenue: 8584558.823529411
Gross profit: 84558.82352941176
Operating income: -1969117.6470588234
Net income: -1462500
Capital expenditures: 2017647.0588235292
Operating cash flow: 1144852.9411764706
Depreciation & amortization: 2706617.647058823
Net tangible assets: 29350735.294117644
Owner earnings: -773529.411764706
Return on net tangible assets (%): -2.63546859733948
Buffett classification: The Gruesome
Stock price: 4.78
Shares outstanding: 15657325
Book value: 29350735.294117644
P/B ratio: 2.5499195420497536
Market cap (USD): 74842013.5
Debt to equity: 0.02136934138337049
Current ratio: 27.494960806270996
Quick ratio: 27.494960806270996
Interest coverage ratio: -55.79166666666667
COGS to revenue (%): 99.0149892933619
SG&A to revenue (%): 23.922912205567453
Free cash flow (dilution-adjusted): -1292647.0588235294
Buyback yield (%): 0
Retained earnings: -138667647.05882353
Receivables turnover: 2.05654394926898
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.655565772796182
FCF margin (%): -15.057815845824413
Revenue growth (%): 24.893834972542955
Rule of 40 score: 9.836019126718542
Financial ratios for BTCT — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 28828125
Buffett classification: The Gruesome
Stock price: 3.12
Shares outstanding: 15657325
Book value: 28828125
P/B ratio: 1.6945553691056912
Market cap (USD): 48850854
Debt to equity: 0.008888888888888889
Current ratio: 75.20938628158845
Quick ratio: 75.20938628158845
Buyback yield (%): 0
Retained earnings: -151118750
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for C7A.AX — annual report dated 2021-06-30
Operating income: -1069921.8045112782
Net income: -992642.857142857
Capital expenditures: 31032.330827067668
Depreciation & amortization: 32651.12781954887
Net tangible assets: 10984841.353383457
Owner earnings: -991024.0601503759
Return on net tangible assets (%): -9.02174212871203
Buffett classification: The Gruesome
Stock price: 0.07518796992481203
Shares outstanding: 2232511417
Book value: 10984841.353383457
P/B ratio: 15.280876243742316
Market cap (USD): 167858001.27819547
Debt to equity: 0.12062241069186322
Current ratio: 0.9003798198725333
Quick ratio: 0.9003798198725333
Interest coverage ratio: -200.30912162162164
Free cash flow (dilution-adjusted): -1791338.3458646615
Buyback yield (%): 0.1429977009609174
Retained earnings: -15322433.834586466
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.3054407358159
Rule of 40 score: 0
Financial ratios for C7A.AX — annual report dated 2022-06-30
Operating income: -1012320.6896551724
Net income: 2895073.103448276
Capital expenditures: 1099640
Depreciation & amortization: 30430.344827586207
Net tangible assets: 13651871.724137932
Owner earnings: 1825863.4482758623
Return on net tangible assets (%): 13.374455057672021
Buffett classification: The Gruesome
Stock price: 0.06896551724137931
P/E ratio: 53.182181975751426
Shares outstanding: 2232511417
Book value: 13651871.72413793
P/B ratio: 11.278036281901272
Market cap (USD): 153966304.62068966
Debt to equity: 0.002681355200302457
Current ratio: 3.8671310753463044
Quick ratio: 3.8671310753463044
Interest coverage ratio: -898.8763012859766
Free cash flow (dilution-adjusted): -2301526.896551724
Buyback yield (%): 0.0283537183810066
Retained earnings: -11159297.241379311
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -7.172404148591287
Rule of 40 score: 0
Financial ratios for C7A.AX — annual report dated 2023-06-30
Operating income: -1410274.834437086
Net income: -6702519.205298013
Capital expenditures: 33112.58278145696
Depreciation & amortization: 13152.317880794702
Net tangible assets: 8374514.569536424
Owner earnings: -6722479.470198676
Return on net tangible assets (%): -80.27306435948803
Buffett classification: The Gruesome
Stock price: 0.026490066225165563
Shares outstanding: 2232511417
Book value: 8374514.569536423
P/B ratio: 7.061827260996921
Market cap (USD): 59139375.28476821
Debt to equity: 0
Current ratio: 2.1985364226748993
Quick ratio: 2.1985364226748993
Interest coverage ratio: -541.7234800305266
Free cash flow (dilution-adjusted): -1073488.0794701986
Buyback yield (%): 0.22420825989442186
Retained earnings: -17418400.662251655
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -16.84007858278946
Rule of 40 score: 0
Financial ratios for CNK — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 15.82
Shares outstanding: 116787759
Market cap (USD): 1847582347.38
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CNK — annual report dated 2022-12-31
Total revenue: 2454700000
Gross profit: 1581000000
Operating income: 77000000
Net income: -267400000
Capital expenditures: 96300000
Operating cash flow: 136000000
Depreciation & amortization: 238200000
Net tangible assets: -1445300000
Owner earnings: -125500000
Capex to operating income (%): 125.06493506493506
Buffett classification: The Gruesome
Stock price: 8.5
Shares outstanding: 116787759
Book value: 119500000
P/B ratio: 8.30707909205021
Market cap (USD): 992695951.5
Debt to equity: 31.606694560669457
Current ratio: 1.2189131968948483
Quick ratio: 1.1854622441778404
Interest coverage ratio: 0.43137254901960786
COGS to revenue (%): 35.592944147961056
SG&A to revenue (%): 34.977797694219255
Free cash flow (dilution-adjusted): 3800000
Buyback yield (%): 0.43316384976714595
Retained earnings: -660600000
Inventory turnover: 36.86497890295359
Receivables turnover: 21.40104620749782
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.8738440572374184
FCF margin (%): 0.15480506782906261
Rule of 40 score: 0.15480506782906261
Financial ratios for CNK — annual report dated 2023-12-31
Total revenue: 3066700000
Gross profit: 1979700000
Operating income: 371800000
Net income: 191500000
Capital expenditures: 146600000
Operating cash flow: 444300000
Depreciation & amortization: 209500000
Net tangible assets: -1244000000
Owner earnings: 254400000
Return on net tangible assets (%): -20.45016077170418
Capex to operating income (%): 39.429800968262505
Buffett classification: The Good
Stock price: 13.83
P/E ratio: 8.434332673472586
Shares outstanding: 116787759
Book value: 318800000
P/B ratio: 5.066420034410288
Market cap (USD): 1615174706.97
Debt to equity: 11.143977415307402
Current ratio: 1.451458304806244
Quick ratio: 1.4195536081062576
Effective tax rate (%): 13.504968383017163
Interest coverage ratio: 2.1491329479768786
COGS to revenue (%): 35.44526689927283
SG&A to revenue (%): 30.37793067466658
Free cash flow (dilution-adjusted): 269800000
Buyback yield (%): 0
Retained earnings: -472400000
Inventory turnover: 46.652360515021456
Receivables turnover: 22.36834427425237
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.053938877389504
FCF margin (%): 8.797730459451527
Revenue growth (%): 24.931763555627978
Rule of 40 score: 33.7294940150795
Financial ratios for CNK — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 27.33
Shares outstanding: 116787759
Market cap (USD): 3191809453.47
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CNK — annual report dated 2024-12-31
Total revenue: 3049500000
Gross profit: 1964500000
Operating income: 362400000
Net income: 312900000
Capital expenditures: 147500000
Operating cash flow: 466000000
Depreciation & amortization: 197500000
Net tangible assets: -945700000
Owner earnings: 362900000
Return on net tangible assets (%): -38.37369144549012
Capex to operating income (%): 40.700883002207505
Buffett classification: The Good
Stock price: 30.41
P/E ratio: 11.350321991658676
Shares outstanding: 116787759
Book value: 603400000
P/B ratio: 5.885839826300962
Market cap (USD): 3551515751.19
Debt to equity: 5.727709645343056
Current ratio: 1.0129515487243506
Quick ratio: 0.9887649215885153
Effective tax rate (%): -23.77373417721519
Interest coverage ratio: 2.183132530120482
COGS to revenue (%): 35.57960321364158
SG&A to revenue (%): 30.99524512215117
Free cash flow (dilution-adjusted): 281700000
Buyback yield (%): 0
Retained earnings: -162700000
Inventory turnover: 35
Receivables turnover: 18.905765654060755
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.573877896071647
FCF margin (%): 9.237579931136251
Revenue growth (%): -0.5608634688753383
Rule of 40 score: 8.676716462260913
Financial ratios for CNK — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 30.41
Shares outstanding: 116787759
Market cap (USD): 3551515751.19
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CNK — quarterly report dated 2025-03-31
Total revenue: 540700000
Gross profit: 355000000
Operating income: -23300000
Net income: -38500000
Capital expenditures: 15300000
Operating cash flow: -119100000
Depreciation & amortization: 49500000
Net tangible assets: -1194300000
Owner earnings: -4300000
Buffett classification: The Gruesome
Stock price: 24.51
Shares outstanding: 116787759
Book value: 357600000
P/B ratio: 8.004664354278525
Market cap (USD): 2862467973.09
Debt to equity: 9.689597315436242
Current ratio: 0.7888516493208679
Quick ratio: 0.7615981654612807
Interest coverage ratio: -0.6051948051948052
COGS to revenue (%): 34.34436841131866
SG&A to revenue (%): 41.261327908267056
Free cash flow (dilution-adjusted): -149400000
Buyback yield (%): 0
Retained earnings: -211700000
Inventory turnover: 6.009708737864078
Receivables turnover: 4.468595041322314
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.6566339758764514
FCF margin (%): -27.630848899574627
Rule of 40 score: -27.630848899574627
Financial ratios for CNK — quarterly report dated 2025-06-30
Total revenue: 940500000
Gross profit: 596600000
Operating income: 176100000
Net income: 94700000
Capital expenditures: 29900000
Operating cash flow: 275900000
Depreciation & amortization: 49400000
Net tangible assets: -553900000
Owner earnings: 114200000
Return on net tangible assets (%): -20.617439971113917
Capex to operating income (%): 16.978989210675753
Buffett classification: The Great
Stock price: 29.79
P/E ratio: 61.90582456601424
Shares outstanding: 116787759
Book value: 1001100000
P/B ratio: 3.4752845276296074
Market cap (USD): 3479107340.61
Debt to equity: 2.995704724802717
Current ratio: 1.538040775733466
Quick ratio: 1.496767777225261
Effective tax rate (%): 30.976676384839653
Interest coverage ratio: 3.9395973154362416
COGS to revenue (%): 36.56565656565657
SG&A to revenue (%): 26.198830409356727
Free cash flow (dilution-adjusted): 238200000
Buyback yield (%): 0
Retained earnings: -185100000
Inventory turnover: 10.358433734939759
Receivables turnover: 4.144997796386074
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.209695926563397
FCF margin (%): 25.32695374800638
Revenue growth (%): 73.94118734973183
Rule of 40 score: 99.26814109773821
Financial ratios for CNK — quarterly report dated 2025-09-30
Total revenue: 857500000
Gross profit: 546400000
Operating income: 118000000
Net income: 50500000
Capital expenditures: 53400000
Operating cash flow: 91500000
Depreciation & amortization: 50900000
Net tangible assets: -991000000
Owner earnings: 48000000
Return on net tangible assets (%): -4.843592330978809
Capex to operating income (%): 45.2542372881356
Buffett classification: The Good
Stock price: 27.75
P/E ratio: 30.37357368556701
Shares outstanding: 116787759
Book value: 564900000
P/B ratio: 5.737051358204993
Market cap (USD): 3240860312.25
Debt to equity: 5.246238272260577
Current ratio: 1.0073635765943458
Quick ratio: 0.9679158448389218
Effective tax rate (%): -82.97101449275362
Interest coverage ratio: 3.1466666666666665
COGS to revenue (%): 36.2798833819242
SG&A to revenue (%): 29.16618075801749
Free cash flow (dilution-adjusted): 27800000
Buyback yield (%): 0
Retained earnings: -633400000
Inventory turnover: 10.37
Receivables turnover: 3.7659200702678963
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.17930755759127
FCF margin (%): 3.24198250728863
Revenue growth (%): -8.825093035619352
Rule of 40 score: -5.583110528330722
Financial ratios for CNK — quarterly report dated 2025-12-31
Total revenue: 776300000
Gross profit: 499500000
Operating income: 71000000
Net income: 34900000
Capital expenditures: 110600000
Operating cash flow: 147800000
Depreciation & amortization: 52100000
Net tangible assets: -1141000000
Owner earnings: -23600000
Capex to operating income (%): 155.77464788732394
Buffett classification: The Gruesome
Stock price: 23.09
P/E ratio: 19.043992622245764
Shares outstanding: 116787759
Book value: 413800000
P/B ratio: 6.516745662904785
Market cap (USD): 2696629355.31
Debt to equity: 7.230062832286128
Current ratio: 0.705764470116704
Quick ratio: 0.6714605681952139
Effective tax rate (%): 17.68867924528302
Interest coverage ratio: 1.8933333333333333
COGS to revenue (%): 35.65631843359526
SG&A to revenue (%): 32.12675512044313
Free cash flow (dilution-adjusted): 24100000
Buyback yield (%): 2.7849581868608944
Retained earnings: -64400000
Inventory turnover: 9.512027491408935
Receivables turnover: 4.363687464867903
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.9801427933958053
FCF margin (%): 3.1044699214221305
Revenue growth (%): -9.46938775510204
Rule of 40 score: -6.36491783367991
Financial ratios for CNK — annual report dated 2025-12-31
Total revenue: 3115000000
Gross profit: 1997500000
Operating income: 341800000
Net income: 141500000
Capital expenditures: 209200000
Operating cash flow: 396100000
Depreciation & amortization: 201900000
Net tangible assets: -1141000000
Owner earnings: 134200000
Return on net tangible assets (%): -11.761612620508325
Capex to operating income (%): 61.20538326506729
Buffett classification: The Good
Stock price: 23.09
P/E ratio: 19.05745127427562
Shares outstanding: 116787759
Book value: 413800000
P/B ratio: 6.516745662904785
Market cap (USD): 2696629355.31
Debt to equity: 7.230062832286128
Current ratio: 0.705764470116704
Quick ratio: 0.6714605681952139
Effective tax rate (%): 8.057179987004549
Interest coverage ratio: 2.089242053789731
COGS to revenue (%): 35.87479935794543
SG&A to revenue (%): 31.107544141252006
Free cash flow (dilution-adjusted): 140700000
Buyback yield (%): 10.201624463454488
Retained earnings: -64400000
Inventory turnover: 38.402061855670105
Receivables turnover: 17.509836987071388
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.532574743418117
FCF margin (%): 4.51685393258427
Revenue growth (%): 2.147893097229054
Rule of 40 score: 6.664747029813324
Financial ratios for CONSOFINVT.NS — annual report dated 2022-03-31
Total revenue: 250019.78108927867
Gross profit: 232124.48898852698
Operating income: 1530871.686667546
Net income: 80522.22075695635
Capital expenditures: 817.6183568508507
Operating cash flow: -874126.3352235263
Depreciation & amortization: 4523.275748384544
Net tangible assets: 66218251.35170777
Owner earnings: 84227.87814849004
Return on net tangible assets (%): 0.12719737599400954
Capex to operating income (%): 0.05340867977189325
Buffett classification: The Great
Stock price: 1.8199920875642885
P/E ratio: 730.65210803472
Shares outstanding: 32326366
Book value: 66218251.35170777
P/B ratio: 0.8884820897371811
Market cap (USD): 58833730.33970724
Debt to equity: 0
Current ratio: 331.80984340044745
Quick ratio: 331.80984340044745
Effective tax rate (%): 76.58615378836258
Interest coverage ratio: 85.9259807549963
COGS to revenue (%): 7.15755050371855
SG&A to revenue (%): 13.624136294108338
Free cash flow (dilution-adjusted): -874943.9535803772
Buyback yield (%): 0
Retained earnings: 4362785.177370434
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.1621772640409467
FCF margin (%): -349.94989187193414
Rule of 40 score: -349.94989187193414
Financial ratios for CONSOFINVT.NS — annual report dated 2023-03-31
Total revenue: 276077.95371498173
Gross profit: 257624.84774665046
Operating income: 49260170.52375153
Net income: 38116419.00121803
Capital expenditures: 0
Operating cash flow: 936686.9671132766
Depreciation & amortization: 3702.801461632156
Net tangible assets: 90542630.93788064
Owner earnings: 38120121.80267966
Return on net tangible assets (%): 42.10184904924296
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.2244823386114496
P/E ratio: 1.0384780437329317
Shares outstanding: 32326366
Book value: 90542630.93788064
P/B ratio: 0.4371759891276712
Market cap (USD): 39583064.23848965
Debt to equity: 0
Current ratio: 201.89423076923077
Quick ratio: 201.89423076923077
Effective tax rate (%): 23.816108351419086
COGS to revenue (%): 6.684020118238772
SG&A to revenue (%): 8.616429894996912
Free cash flow (dilution-adjusted): 936686.9671132766
Buyback yield (%): 0
Retained earnings: 34522728.380024366
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 47.07714976194625
FCF margin (%): 339.28350833848054
Revenue growth (%): 10.422444381070012
Rule of 40 score: 349.70595271955057
Financial ratios for CONSOFINVT.NS — annual report dated 2024-03-31
Total revenue: 1627113.5627773113
Gross profit: 1605624.1755606188
Operating income: 5904604.868689291
Net income: 5570751.888715673
Capital expenditures: 0
Operating cash flow: 1664851.900707519
Depreciation & amortization: 3141.8635327976976
Net tangible assets: 96912375.58460248
Owner earnings: 5573893.752248471
Return on net tangible assets (%): 5.751477784571051
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.651031669865643
P/E ratio: 15.383600230206183
Shares outstanding: 32326366
Book value: 96912375.58460248
P/B ratio: 0.8842856190523902
Market cap (USD): 85698220.03766795
Debt to equity: 0
Current ratio: 1915.9156626506024
Quick ratio: 1915.9156626506024
Effective tax rate (%): 8.721978820801981
Interest coverage ratio: 2051.6041666666665
COGS to revenue (%): 1.320706047094373
SG&A to revenue (%): 2.3679846703762393
Free cash flow (dilution-adjusted): 1664851.900707519
Buyback yield (%): 0
Retained earnings: 38445281.20877803
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.316443860140875
FCF margin (%): 102.31934259498104
Revenue growth (%): 489.3674380306065
Rule of 40 score: 591.6867806255875
Financial ratios for CONSOFINVT.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 110320114.66794075
Buffett classification: The Gruesome
Stock price: 2.611084567606307
Shares outstanding: 32326366
Book value: 110320114.66794075
P/B ratio: 0.765108662581204
Market cap (USD): 84406875.38939321
Debt to equity: 0
Current ratio: 10.582089552238806
Quick ratio: 10.582089552238806
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CONSOFINVT.NS — quarterly report dated 2024-12-31
Total revenue: 109569.87993938687
Gross profit: 103741.694836228
Operating income: 1633057.465905117
Net income: 1774099.5454015618
Capital expenditures: 0
Depreciation & amortization: 0
Owner earnings: 1774099.5454015618
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.4387457745658
P/E ratio: 11.109267895072273
Shares outstanding: 32326366
Market cap (USD): 78835788.48956753
Effective tax rate (%): 11.247086247086248
COGS to revenue (%): 5.319148936170213
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CONSOFINVT.NS — quarterly report dated 2025-03-31
Total revenue: 114575.33539864389
Gross profit: 100359.76373626372
Operating income: 1571753.2638531679
Net income: 2680991.3490764555
Capital expenditures: 0
Depreciation & amortization: 923.5445405658171
Net tangible assets: 120111503.39022678
Owner earnings: 2681914.8936170214
Return on net tangible assets (%): 2.232854321125118
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.0504142840471467
P/E ratio: 6.180777366231424
Shares outstanding: 32326366
Book value: 120111503.39022678
P/B ratio: 0.5518409205352539
Market cap (USD): 66282442.59773602
Debt to equity: 0
Current ratio: 12086.011029411764
Quick ratio: 12086.011029411764
Effective tax rate (%): -2.062094325679129
COGS to revenue (%): 12.407183110500785
Buyback yield (%): 0
Retained earnings: 47223766.65887304
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.1963602123603452
Revenue growth (%): 4.568276849464466
Rule of 40 score: 4.568276849464466
Financial ratios for CONSOFINVT.NS — annual report dated 2025-03-31
Total revenue: 149269.53624035537
Gross profit: 100359.76373626372
Operating income: 1571753.2638531679
Net income: 12657610.474631751
Capital expenditures: 0
Operating cash flow: 1168131.868131868
Depreciation & amortization: 2501.7535655833526
Net tangible assets: 120111503.39022678
Owner earnings: 12660112.228197334
Return on net tangible assets (%): 10.540299530733757
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.0504142840471467
P/E ratio: 5.236568365773191
Shares outstanding: 32326366
Book value: 120111503.39022678
P/B ratio: 0.5518409205352539
Market cap (USD): 66282442.59773602
Debt to equity: 0
Current ratio: 32873.95
Quick ratio: 32873.95
Effective tax rate (%): -52.75370824433641
COGS to revenue (%): 19.704717246576404
SG&A to revenue (%): 12.546485305649998
Free cash flow (dilution-adjusted): 1168131.868131868
Buyback yield (%): 0
Retained earnings: 47223766.65887304
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.1963419022017683
FCF margin (%): 782.5654835899871
Revenue growth (%): -90.82611443631703
Rule of 40 score: 691.7393691536702
Financial ratios for CONSOFINVT.NS — quarterly report dated 2025-06-30
Total revenue: 15211.794991809034
Gross profit: 8190.966534051018
Operating income: 1721273.110227007
Net income: 1481394.8045869414
Capital expenditures: 0
Depreciation & amortization: 0
Owner earnings: 1481394.8045869414
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.4213667212731105
P/E ratio: 13.185239688933017
Shares outstanding: 32326366
Market cap (USD): 78273986.85209456
Effective tax rate (%): 14.919354838709678
COGS to revenue (%): 46.15384615384615
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -86.7233249295039
Rule of 40 score: -86.7233249295039
Financial ratios for CONSOFINVT.NS — quarterly report dated 2025-09-30
Total revenue: 453213.0777903044
Gross profit: 446448.7034949267
Operating income: 2034949.2671927847
Net income: 1771138.6696730552
Capital expenditures: 0
Depreciation & amortization: 1127.3957158962796
Net tangible assets: 117069898.53438556
Owner earnings: 1772266.0653889515
Return on net tangible assets (%): 1.5138529097370017
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.05456595264938
P/E ratio: 8.617006716864314
Shares outstanding: 32326366
Book value: 117069898.53438556
P/B ratio: 0.5673247503240532
Market cap (USD): 66416650.95648253
Debt to equity: 0
Current ratio: 125.99999999999999
Quick ratio: 125.99999999999999
Effective tax rate (%): 16.83430386447856
COGS to revenue (%): 1.4925373134328357
Buyback yield (%): 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.5875808083029157
Revenue growth (%): 2879.3530483045697
Rule of 40 score: 2879.3530483045697
Financial ratios for DCGO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.35
Shares outstanding: 98778413
Market cap (USD): 923578161.55
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DCGO — annual report dated 2022-12-31
Total revenue: 440515746
Gross profit: 154721226
Operating income: 21831628
Net income: 34584498
Capital expenditures: 3195234
Operating cash flow: 28869901
Depreciation & amortization: 10565578
Net tangible assets: 211361007
Owner earnings: 41954842
Return on net tangible assets (%): 19.84984959879568
Capex to operating income (%): 14.635802698726819
Buffett classification: The Great
Stock price: 7.07
P/E ratio: 20.19295986051323
Shares outstanding: 98778413
Book value: 278927391
P/B ratio: 2.503746144852443
Market cap (USD): 698363379.9100001
Debt to equity: 0.07139608243064231
Current ratio: 2.706519487264634
Quick ratio: 2.706519487264634
Effective tax rate (%): -34.94582890657194
COGS to revenue (%): 64.87725412657554
R&D to revenue (%): 1.2223973941671542
SG&A to revenue (%): 26.5459675532234
Free cash flow (dilution-adjusted): 15317538
Buyback yield (%): 0.5343510423586235
Retained earnings: -28972216
Receivables turnover: 4.277043041059398
Capitalized R&D asset: 5384853
ROCI (R&D-adjusted, %): 8.516311595981307
FCF margin (%): 3.4771828564784153
Rule of 40 score: 3.4771828564784153
Financial ratios for DCGO — annual report dated 2023-12-31
Total revenue: 624288642
Gross profit: 195382417
Operating income: 15054980
Net income: 10048328
Capital expenditures: 6566181
Operating cash flow: -64493170
Depreciation & amortization: 16431892
Net tangible assets: 215572010
Owner earnings: 19914039
Return on net tangible assets (%): 9.237766535646255
Capex to operating income (%): 43.61467766812045
Buffett classification: The Good
Stock price: 5.59
P/E ratio: 54.951562953558046
Shares outstanding: 98778413
Book value: 305170956
P/B ratio: 1.8093836186363685
Market cap (USD): 552171328.67
Debt to equity: 0.15236424727129014
Current ratio: 1.9919550353557633
Quick ratio: 1.9919550353557633
Effective tax rate (%): 38.3284398064897
COGS to revenue (%): 68.70319210452655
R&D to revenue (%): 1.7393755499399266
SG&A to revenue (%): 24.51379229161116
Free cash flow (dilution-adjusted): -95317274
Buyback yield (%): 0
Retained earnings: -21394310
Receivables turnover: 2.382022265868878
Capitalized R&D asset: 14466575.51
ROCI (R&D-adjusted, %): 6.1228231713364325
Rosenberg metric: 7.55103082665395
FCF margin (%): -15.268141623502418
Revenue growth (%): 41.717667908288576
Rule of 40 score: 26.44952628478616
Financial ratios for DCGO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.32
Shares outstanding: 98778413
Market cap (USD): 327944331.15999997
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DCGO — annual report dated 2024-12-31
Total revenue: 616555132
Gross profit: 213574575
Operating income: 28688726
Net income: 19992143
Capital expenditures: 3338080
Operating cash flow: 70115431
Depreciation & amortization: 15884898
Net tangible assets: 247756113
Owner earnings: 32538961
Return on net tangible assets (%): 13.13346444049193
Capex to operating income (%): 11.635511454917866
Buffett classification: The Great
Stock price: 4.24
P/E ratio: 20.94925347022578
Shares outstanding: 98778413
Book value: 315179130
P/B ratio: 1.3288331340974258
Market cap (USD): 418820471.12
Debt to equity: 0.18144274971505886
Current ratio: 2.4997522342328033
Quick ratio: 2.4997522342328033
Effective tax rate (%): 51.85203417405786
Interest coverage ratio: 14.87073497037902
COGS to revenue (%): 65.36001990491907
R&D to revenue (%): 1.8797024626826073
SG&A to revenue (%): 25.53081481770879
Free cash flow (dilution-adjusted): 50866735
Buyback yield (%): 3.284526891250874
Retained earnings: -1402167
Receivables turnover: 2.923448783002418
Capitalized R&D asset: 20641748.569999997
ROCI (R&D-adjusted, %): 8.745921012295156
Rosenberg metric: 1.6753495162046663
FCF margin (%): 8.250151910178245
Revenue growth (%): -1.2387715360677665
Rule of 40 score: 7.0113803741104785
Financial ratios for DCGO — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.24
Shares outstanding: 98778413
Market cap (USD): 418820471.12
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DCGO — quarterly report dated 2025-03-31
Total revenue: 96033055
Gross profit: 30847995
Operating income: -13997438
Net income: -9405315
Capital expenditures: 935285
Operating cash flow: 9216729
Depreciation & amortization: 3761391
Net tangible assets: 232439330
Owner earnings: -6579209
Return on net tangible assets (%): -2.830505921695782
Buffett classification: The Gruesome
Stock price: 2.64
Shares outstanding: 98778413
Book value: 301924803
P/B ratio: 0.8637084722052464
Market cap (USD): 260775010.32000002
Debt to equity: 0.20156242678744085
Current ratio: 2.4405387309516913
Quick ratio: 2.4405387309516913
Interest coverage ratio: -32.83594505071736
COGS to revenue (%): 67.8777323079017
R&D to revenue (%): 3.7897825910047325
SG&A to revenue (%): 38.99136396316872
Free cash flow (dilution-adjusted): 2644080
Buyback yield (%): 2.2057151844962872
Retained earnings: -10807482
Receivables turnover: 0.5372301337995572
Capitalized R&D asset: 3639444
ROCI (R&D-adjusted, %): -3.540076614260021
FCF margin (%): 2.7533019750334926
Rule of 40 score: 2.7533019750334926
Financial ratios for DCGO — quarterly report dated 2025-06-30
Total revenue: 80417622
Gross profit: 25419098
Operating income: -17480244
Net income: -11155246
Capital expenditures: 1058269
Operating cash flow: 34043489
Depreciation & amortization: 3981008
Net tangible assets: 220615892
Owner earnings: -8232507
Return on net tangible assets (%): -3.7316019826894427
Buffett classification: The Gruesome
Stock price: 1.57
Shares outstanding: 98778413
Book value: 287730732
P/B ratio: 0.5389834701772489
Market cap (USD): 155082108.41
Debt to equity: 0.2101003586923068
Current ratio: 2.362282242074577
Quick ratio: 2.362282242074577
Interest coverage ratio: -39.3999125460373
COGS to revenue (%): 68.391134470502
R&D to revenue (%): 3.6773071951816725
SG&A to revenue (%): 44.71797363020757
Free cash flow (dilution-adjusted): 27210637
Buyback yield (%): 3.273718710721777
Retained earnings: -21962728
Receivables turnover: 0.6551003842722968
Capitalized R&D asset: 5395630.48
ROCI (R&D-adjusted, %): -5.3337300937335845
Rosenberg metric: -1.4916830702711732
FCF margin (%): 33.83665958190109
Revenue growth (%): -16.26047718673534
Rule of 40 score: 17.57618239516575
Financial ratios for DCGO — quarterly report dated 2025-09-30
Total revenue: 70809635
Gross profit: 18126110
Operating income: -25237568
Net income: -27768386
Capital expenditures: 855339
Operating cash flow: 1658736
Depreciation & amortization: 3971232
Net tangible assets: 211503830
Owner earnings: -24652493
Return on net tangible assets (%): -11.655813986914563
Buffett classification: The Gruesome
Stock price: 1.36
Shares outstanding: 98778413
Book value: 260661887
P/B ratio: 0.5153750831244462
Market cap (USD): 134338641.68
Debt to equity: 0.11303523249641786
Current ratio: 2.5851498855058876
Quick ratio: 2.5851498855058876
COGS to revenue (%): 74.40163333704515
R&D to revenue (%): 4.509951223445793
SG&A to revenue (%): 51.121526046561314
Free cash flow (dilution-adjusted): -4548512
Buyback yield (%): 0
Retained earnings: -49731114
Receivables turnover: 0.6616760498657565
Capitalized R&D asset: 6375822.529999999
ROCI (R&D-adjusted, %): -8.831022165184683
Rosenberg metric: -2.466177668560461
FCF margin (%): -6.4235778083024995
Revenue growth (%): -11.947613919745102
Rule of 40 score: -18.371191728047602
Financial ratios for DCGO — annual report dated 2025-12-31
Total revenue: 322196000
Gross profit: 98757699
Operating income: -89157159
Net income: -182399628
Capital expenditures: 4341951
Operating cash flow: 34451654
Depreciation & amortization: 15661865
Net tangible assets: 144011839
Owner earnings: -171079714
Return on net tangible assets (%): -118.79559013200296
Buffett classification: The Gruesome
Stock price: 0.88
Shares outstanding: 98778413
Book value: 125871337
P/B ratio: 0.6905861613275786
Market cap (USD): 86925003.44
Debt to equity: 0.23180649936212244
Current ratio: 2.2581027578496538
Quick ratio: 2.2581027578496538
COGS to revenue (%): 69.34856453835553
R&D to revenue (%): 4.209571192690164
SG&A to revenue (%): 49.252604936125834
Free cash flow (dilution-adjusted): 9574802
Buyback yield (%): 12.457757344208394
Retained earnings: -183801795
Receivables turnover: 3.468455651271671
Capitalized R&D asset: 24911348.26
ROCI (R&D-adjusted, %): -50.19233071989038
Rosenberg metric: -9.907057844744708
FCF margin (%): 2.971732113371985
Revenue growth (%): -47.74254835008007
Rule of 40 score: -44.770816236708086
Financial ratios for DCGO — quarterly report dated 2025-12-31
Total revenue: 74935688
Gross profit: 24364496
Operating income: -32441909
Net income: -134070681
Capital expenditures: 1493058
Operating cash flow: -10467300
Depreciation & amortization: 3948234
Net tangible assets: 144011839
Owner earnings: -131615505
Return on net tangible assets (%): -91.39214241962426
Buffett classification: The Gruesome
Stock price: 0.88
Shares outstanding: 98778413
Book value: 125871337
P/B ratio: 0.6905861613275786
Market cap (USD): 86925003.44
Debt to equity: 0.23180649936212244
Current ratio: 2.2581027578496538
Quick ratio: 2.2581027578496538
COGS to revenue (%): 67.48612490219614
R&D to revenue (%): 5.0349080667678665
SG&A to revenue (%): 65.5031391718189
Free cash flow (dilution-adjusted): -15731403
Buyback yield (%): 0
Retained earnings: -183801795
Receivables turnover: 0.8066863354154947
Capitalized R&D asset: 6888451.59
ROCI (R&D-adjusted, %): -20.432301397490065
Rosenberg metric: 1.9534758320077157
FCF margin (%): -20.993205533790523
Revenue growth (%): 5.82696549699769
Rule of 40 score: -15.166240036792832
Financial ratios for EPM — annual report dated 2021-06-30
Operating income: 4194000
Capital expenditures: 0
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.31
Shares outstanding: 35821410
Market cap (USD): 118568867.10000001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EPM — annual report dated 2022-06-30
Total revenue: 108926000
Gross profit: 52747000
Operating income: 45381000
Net income: 32628000
Capital expenditures: 53342000
Operating cash flow: 52460000
Depreciation & amortization: 8053000
Net tangible assets: 75514000
Owner earnings: -12661000
Return on net tangible assets (%): -16.766427417432528
Capex to operating income (%): 117.54258390075141
Buffett classification: The Gruesome
Stock price: 3.87
P/E ratio: 4.248769667157044
Shares outstanding: 35821410
Book value: 75514000
P/B ratio: 1.83580338347856
Market cap (USD): 138628856.70000002
Debt to equity: 0.2817490796408613
Current ratio: 1.2008585108139342
Quick ratio: 1.2008585108139342
Effective tax rate (%): 20.692253469774677
Interest coverage ratio: 79.33741258741259
COGS to revenue (%): 51.57538145162771
SG&A to revenue (%): 6.274902227200117
Free cash flow (dilution-adjusted): -2538000
Buyback yield (%): 0.02741132034453256
Retained earnings: 32852000
Receivables turnover: 4.081153990258524
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 38.536200132470576
FCF margin (%): -2.3300222169179077
Rule of 40 score: -2.3300222169179077
Financial ratios for EPM — annual report dated 2023-06-30
Total revenue: 128514000
Gross profit: 55827000
Operating income: 45113000
Net income: 35217000
Capital expenditures: 31000
Operating cash flow: 51272000
Depreciation & amortization: 14273000
Net tangible assets: 92094000
Owner earnings: 49459000
Return on net tangible assets (%): 53.704910200447365
Capex to operating income (%): 0.0687163345377164
Buffett classification: The Great
Stock price: 6.11
P/E ratio: 6.214862569213732
Shares outstanding: 35821410
Book value: 92094000
P/B ratio: 2.376580614372272
Market cap (USD): 218868815.10000002
Debt to equity: 0.0019979586075097185
Current ratio: 1.7255556460148171
Quick ratio: 1.7255556460148171
Effective tax rate (%): 22.23939587979421
Interest coverage ratio: 98.5
COGS to revenue (%): 56.55959661982352
SG&A to revenue (%): 7.456775137339122
Free cash flow (dilution-adjusted): 42641000
Buyback yield (%): 1.9052508682402967
Retained earnings: 51963000
Receivables turnover: 15.579342950660687
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 38.87912163676164
FCF margin (%): 33.180042641268656
Revenue growth (%): 17.98285074270606
Rule of 40 score: 51.16289338397472
Financial ratios for EPM — annual report dated 2024-06-30
Total revenue: 85877000
Gross profit: 18999000
Operating income: 7906000
Net income: 4080000
Capital expenditures: 38734000
Operating cash flow: 22729000
Depreciation & amortization: 20062000
Net tangible assets: 81127000
Owner earnings: -14592000
Return on net tangible assets (%): -17.986613581175195
Capex to operating income (%): 489.93169744497845
Buffett classification: The Gruesome
Stock price: 4.32
P/E ratio: 37.92855176470588
Shares outstanding: 35821410
Book value: 81127000
P/B ratio: 1.9074844527715806
Market cap (USD): 154748491.20000002
Debt to equity: 0.48881383509805615
Current ratio: 1.3737431227471069
Quick ratio: 1.3737431227471069
Effective tax rate (%): 25.777696925595777
Interest coverage ratio: 5.418779986291981
COGS to revenue (%): 77.87649778171105
SG&A to revenue (%): 11.22069937235814
Free cash flow (dilution-adjusted): -29041000
Buyback yield (%): 0.7392640736777664
Retained earnings: 40003000
Receivables turnover: 7.67307005003574
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.375890768644943
FCF margin (%): -33.81697078379543
Revenue growth (%): -33.176930139906936
Rule of 40 score: -66.99390092370237
Financial ratios for EPM — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.45
Shares outstanding: 35821410
Market cap (USD): 159405274.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EPM — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.48
Shares outstanding: 35821410
Market cap (USD): 160479916.8
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EPM — quarterly report dated 2025-03-31
Total revenue: 22561000
Gross profit: 4159000
Operating income: 1586000
Net income: -2179000
Capital expenditures: 20000
Operating cash flow: 7263000
Depreciation & amortization: 5014000
Net tangible assets: 71660000
Owner earnings: 2815000
Capex to operating income (%): 1.2610340479192939
Buffett classification: The Great
Stock price: 4.54
Shares outstanding: 35821410
Book value: 71660000
P/B ratio: 2.2694557828635222
Market cap (USD): 162629201.4
Debt to equity: 0.49663689645548426
Current ratio: 0.8788739898765652
Quick ratio: 0.8788739898765652
Interest coverage ratio: 2.249645390070922
COGS to revenue (%): 81.56553344266655
SG&A to revenue (%): 11.404636319312088
Free cash flow (dilution-adjusted): 2197000
Buyback yield (%): 0.043657596168949764
Retained earnings: 25840000
Receivables turnover: 2.064324274865038
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.1847137564240469
FCF margin (%): 9.738043526439432
Rule of 40 score: 9.738043526439432
Financial ratios for EPM — annual report dated 2025-06-30
Total revenue: 85840000
Gross profit: 16128000
Operating income: 4175000
Net income: 1473000
Capital expenditures: 9019000
Operating cash flow: 33052000
Depreciation & amortization: 21993000
Net tangible assets: 71813000
Owner earnings: 14447000
Return on net tangible assets (%): 20.11752746717168
Capex to operating income (%): 216.0239520958084
Buffett classification: The Gruesome
Stock price: 4.22
P/E ratio: 102.62481344195518
Shares outstanding: 35821410
Book value: 71813000
P/B ratio: 2.1049997939091805
Market cap (USD): 151166350.2
Debt to equity: 0.5231086293568017
Current ratio: 0.8124094075840463
Quick ratio: 0.8124094075840463
Effective tax rate (%): 21.187800963081862
Interest coverage ratio: 1.4057239057239057
COGS to revenue (%): 81.21155638397018
SG&A to revenue (%): 12.038676607642126
Free cash flow (dilution-adjusted): 8928000
Buyback yield (%): 0.2923931148798749
Retained earnings: 25129000
Receivables turnover: 7.781706100988124
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.0065171209448027
FCF margin (%): 10.400745573159366
Revenue growth (%): -0.043084877208099955
Rule of 40 score: 10.357660695951266
Financial ratios for EPM — quarterly report dated 2025-06-30
Total revenue: 21108000
Gross profit: 5539000
Operating income: 1340000
Net income: 3412000
Capital expenditures: 8668000
Operating cash flow: 10456000
Depreciation & amortization: 5821000
Net tangible assets: 71813000
Owner earnings: 565000
Return on net tangible assets (%): 0.7867656273933689
Capex to operating income (%): 646.865671641791
Buffett classification: The Gruesome
Stock price: 4.22
P/E ratio: 122.60044622871044
Shares outstanding: 35821410
Book value: 71813000
P/B ratio: 2.1049997939091805
Market cap (USD): 151166350.2
Debt to equity: 0.5231086293568017
Current ratio: 0.8124094075840463
Quick ratio: 0.8124094075840463
Effective tax rate (%): 22.18928164196123
Interest coverage ratio: 1.9764011799410028
COGS to revenue (%): 73.75876444949782
SG&A to revenue (%): 12.222853894258101
Free cash flow (dilution-adjusted): -3555000
Buyback yield (%): 0.11907411918184953
Retained earnings: 25129000
Receivables turnover: 1.9135164536306772
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.9649659741475534
FCF margin (%): -16.84195565662308
Revenue growth (%): -6.440317361819068
Rule of 40 score: -23.28227301844215
Financial ratios for EPM — quarterly report dated 2025-09-30
Total revenue: 21288000
Gross profit: 2240000
Operating income: -85000
Net income: 824000
Capital expenditures: 16867000
Operating cash flow: 7805000
Depreciation & amortization: 5961000
Net tangible assets: 69131000
Owner earnings: -10082000
Return on net tangible assets (%): -14.583905917750359
Buffett classification: The Gruesome
Stock price: 4.43
P/E ratio: 77.14576874088478
Shares outstanding: 35821410
Book value: 69131000
P/B ratio: 2.2954802664506517
Market cap (USD): 158688846.29999998
Debt to equity: 0.7672679405765864
Current ratio: 0.6995693753145797
Quick ratio: 0.6995693753145797
Effective tax rate (%): 30.698065601345668
Interest coverage ratio: -0.09269356597600872
COGS to revenue (%): 89.47763998496806
SG&A to revenue (%): 10.921645997745207
Free cash flow (dilution-adjusted): -13418000
Buyback yield (%): 0.08318164954735072
Retained earnings: 21796000
Receivables turnover: 2.4024376481209795
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.05619834710743802
FCF margin (%): -63.03081548290117
Revenue growth (%): 0.8527572484366117
Rule of 40 score: -62.17805823446456
Financial ratios for EPM — quarterly report dated 2025-12-31
Total revenue: 20679000
Gross profit: 3250000
Operating income: 658000
Net income: 1065000
Capital expenditures: 220000
Operating cash flow: 5425000
Depreciation & amortization: 5919000
Net tangible assets: 67544000
Owner earnings: 6764000
Return on net tangible assets (%): 10.01421295747957
Capex to operating income (%): 33.43465045592705
Buffett classification: The Good
Stock price: 3.35
P/E ratio: 38.437451473414484
Shares outstanding: 35821410
Book value: 67544000
P/B ratio: 1.7766452016463343
Market cap (USD): 120001723.5
Debt to equity: 0.8135289589008646
Current ratio: 0.8973125588204538
Quick ratio: 0.8973125588204538
Effective tax rate (%): 44.00630914826498
Interest coverage ratio: 0.6560319042871385
COGS to revenue (%): 84.28357270661057
SG&A to revenue (%): 12.534455244450893
Free cash flow (dilution-adjusted): 4195000
Buyback yield (%): 0.0416660682377616
Retained earnings: 18666000
Receivables turnover: 2.1765077360277867
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.43826054522808866
FCF margin (%): 20.286280767928815
Revenue growth (%): -2.8607666290868092
Rule of 40 score: 17.425514138842004
Financial ratios for EPRX.TO — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 68875.86614173229
Buffett classification: The Gruesome
Stock price: 1.9291338582677167
Shares outstanding: 65326947
Market cap (USD): 126024425.31496064
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EPRX.TO — annual report dated 2022-12-31
Total revenue: 0
Operating income: -12954008.823529411
Net income: -13595315.44117647
Capital expenditures: 173020.5882352941
Operating cash flow: -10584706.617647057
Depreciation & amortization: 108745.58823529411
Net tangible assets: 5725386.029411764
Owner earnings: -13659590.44117647
Return on net tangible assets (%): -238.5793791196972
Buffett classification: The Gruesome
Stock price: 2.6838235294117645
Shares outstanding: 65326947
Book value: 5299892.647058822
P/B ratio: 33.081046945457004
Market cap (USD): 175325997.4632353
Debt to equity: 1.2466718942975263
Current ratio: 6.078042772219473
Quick ratio: 6.078042772219473
Interest coverage ratio: -17.924753982272073
Free cash flow (dilution-adjusted): -11812178.676470587
Buyback yield (%): 0
Retained earnings: -56823896.32352941
Receivables turnover: 0
Capitalized R&D asset: 10021951.470588235
ROCI (R&D-adjusted, %): -28.72958934027209
Rule of 40 score: 0
Financial ratios for EPRX.TO — annual report dated 2023-12-31
Total revenue: 0
Operating income: -21096385.606060605
Net income: -21379390.909090906
Capital expenditures: 55588.63636363636
Operating cash flow: -15718650.757575756
Depreciation & amortization: 117823.48484848485
Net tangible assets: 1678944.6969696968
Owner earnings: -21317156.06060606
Return on net tangible assets (%): -1269.6758921887713
Buffett classification: The Gruesome
Stock price: 4.068181818181818
Shares outstanding: 65326947
Book value: 676004.545454545
P/B ratio: 393.1362589345153
Market cap (USD): 265761898.02272728
Debt to equity: 11.713239331813718
Current ratio: 1.0221522219864527
Quick ratio: 1.0221522219864527
Interest coverage ratio: -23.79753164702997
Free cash flow (dilution-adjusted): -16844131.06060606
Buyback yield (%): 0
Retained earnings: -79925223.48484848
Receivables turnover: 0
Capitalized R&D asset: 22141316.57620321
ROCI (R&D-adjusted, %): -62.02581784334546
Rule of 40 score: 0
Financial ratios for EPRX.TO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.6296296296296293
Shares outstanding: 65326947
Market cap (USD): 171785675.44444442
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EPRX.TO — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.1538461538461537
Shares outstanding: 65326947
Market cap (USD): 206031140.53846154
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EPRX.TO — annual report dated 2024-12-31
Total revenue: 0
Operating income: -18883504.195804197
Net income: -17833941.25874126
Capital expenditures: 52558.74125874126
Operating cash flow: -20975168.531468533
Depreciation & amortization: 120083.21678321679
Net tangible assets: 23360002.0979021
Owner earnings: -17766416.783216782
Return on net tangible assets (%): -76.05485953621698
Buffett classification: The Gruesome
Stock price: 3.1538461538461537
Shares outstanding: 65326947
Book value: 22265013.286713287
P/B ratio: 9.253582644902854
Market cap (USD): 206031140.53846154
Debt to equity: 0.0022569512222584843
Current ratio: 11.096485580588428
Quick ratio: 11.096485580588428
Interest coverage ratio: -44.73926269067702
Free cash flow (dilution-adjusted): -23302225.174825177
Buyback yield (%): 0
Retained earnings: -91611070.62937063
Receivables turnover: 0
Capitalized R&D asset: 24887321.02725216
ROCI (R&D-adjusted, %): -42.14042006198671
Rule of 40 score: 0
Financial ratios for EPRX.TO — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -4981972.027972029
Net income: -4729096.503496503
Capital expenditures: 118212.58741258741
Operating cash flow: -4197951.748251748
Depreciation & amortization: 32508.39160839161
Net tangible assets: 20002579.72027972
Owner earnings: -4814800.699300699
Return on net tangible assets (%): -24.070898687228766
Buffett classification: The Gruesome
Stock price: 3.286713286713287
Shares outstanding: 65326947
Book value: 18904327.272727273
P/B ratio: 11.357767012162975
Market cap (USD): 214710944.68531471
Debt to equity: 0.001952192985895707
Current ratio: 13.00296773941348
Quick ratio: 13.00296773941348
Free cash flow (dilution-adjusted): -5360504.895104895
Buyback yield (%): 0
Retained earnings: -96340167.13286714
Receivables turnover: 0
Capitalized R&D asset: 2692186.0139860143
ROCI (R&D-adjusted, %): -14.757851462727487
Rule of 40 score: 0